在D-葡萄糖的快速上升期间的高血压会调解第一阶段胰岛素分泌
1University of Washington Medicine Diabetes Institute, University of Washington, Seattle, WA, United States.
Frontiers in endocrinology
|July 11, 2024
概括
双相胰岛素分泌对于葡萄糖调节至关重要,由透性变化驱动,而不仅仅是新陈代谢. 这一发现重新定义了我们对胰腺小岛的第一阶段胰岛素释放的理解.
科学领域:
- 内分泌学 在内分泌学.
- 代谢研究研究 代谢研究
- 细胞生物学 细胞生物学
背景情况:
- 双相胰岛素分泌是胰腺小岛的一个关键功能.
- 失去第一阶段胰岛素分泌与2型糖尿病有关.
- 已知第一阶段胰岛素分泌是由快速的葡萄糖变化引发的.
研究的目的:
- 测试小岛对葡萄糖的反应涉及代谢和透效应的假设.
- 为了研究超性在驱动第一阶段胰岛素分泌中的作用.
主要方法:
- 对老鼠,小鼠和人类小岛的周流分析.
- 测量胰岛素分泌率 (ISR) 和监管参数.
- 使用D-葡萄糖与隔膜无碳水化合物 (L-葡萄糖或曼尼托尔) 结合,以隔离透效应.
主要成果:
- 第一阶段的反应取决于强度的变化,而不仅仅是葡萄糖代谢.
- 快速增加的L-葡萄糖 (没有D-葡萄糖变化) 模仿了D-葡萄糖诱导的第一阶段反应.
- H89消除了第一阶段的胰岛素分泌,但没有消除第一阶段的反应.
结论:
- 一个新的模型表明,第一阶段胰岛素分泌是由高度诱导的激酶激活驱动的.
- 这种透效应放大了第二阶段胰岛素分泌.
- 这些发现为葡萄糖刺激的胰岛素分泌机制提供了新的见解.
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.2K
Insulin Secretory Vesicles
4.9K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.9K
Hormones Regulating Blood Glucose
3.2K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.2K
Glucose Absorption Into the Small Intestine
31.6K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.6K
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
Glucagon-like Receptor Agonists
313
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
313


